Research progress on clinical adverse outcome events in NAFLD/MAFLD
Medical Journal of Chinese People′s Liberation ArmyVol. 50, Issue 12, Pages: 1608-1617(2025)
Review|更新时间:2026-01-07
分享给微信好友或者朋友圈
导出参考文献
Research progress on clinical adverse outcome events in NAFLD/MAFLD
“There are differences in the association and prediction of adverse outcomes between non-alcoholic fatty liver disease and metabolism related fatty liver disease in extrahepatic diseases, providing reference for multidisciplinary management.”
Hu Xin-Xin,Tian Li-Min.Research progress on clinical adverse outcome events in NAFLD/MAFLD[J].Medical Journal of Chinese People′s Liberation Army,2025,50(12):1608-1617.
Hu Xin-Xin,Tian Li-Min.Research progress on clinical adverse outcome events in NAFLD/MAFLD[J].Medical Journal of Chinese People′s Liberation Army,2025,50(12):1608-1617. DOI: 10.11855/j.issn.0577-7402.1196.2025.0304.
Research progress on clinical adverse outcome events in NAFLD/MAFLD
Clinical characteristics and influencing factors in type 2 diabetes mellitus patients with MAFLD at moderate-to-high risk of metabolic-associated fatty liver fibrosis
Expression of high-mobility group B1 released by exosome in nonalcoholic fatty liver disorder and regulated by TLR4 signal
Grading diagnostic efficiency of controlled attenuation parameter on hepatic steatosis of patients with nonalcoholic fatty liver disease
Related Author
Li Xiao-Hua
Liu Xuan
Li Chang
Zhang Hong-Li
Ma Fu-Quan
Shi Wen
Liu Meng-Ying
Feng Yun
Related Institution
Department of Endocrinology, the Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine
Department of Gastroenterology, the First Affiliated Hospital of Xi'an Jiaotong University
Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital
Peking University Clinical Medical School
School of Biological Science and Medical Engineering , Beihang University